100 项与 NT Pharma International Co., Ltd. 相关的临床结果
0 项与 NT Pharma International Co., Ltd. 相关的专利(医药)
HK-listed pharmaceutical company China NT Pharma Group Company Limited has entered into an agreement to acquire a 40 per cent stake in Beijing Konruns Pharmaceutical’s unit Kangchen for 360 million yuan ($51 million) in a bid to reshuffle its business.
100 项与 NT Pharma International Co., Ltd. 相关的药物交易
100 项与 NT Pharma International Co., Ltd. 相关的转化医学